Clinical Trials Logo

Filter by:
NCT ID: NCT00895583 Completed - Kidney Transplant Clinical Trials

Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

Start date: June 2009
Phase: Phase 4
Study type: Interventional

This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.

NCT ID: NCT00894998 Completed - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin in Patients (Cristália)

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify, through a randomized, single-blind, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery at that require the aid of cardiopulmonary bypass, through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation TCA, TTPA, Anti-Xa, heparin bioavailable and loss of excessive blood (bleeding) at the end of the surgery.

NCT ID: NCT00894985 Completed - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify, through a randomized, open, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery at that require the aid of cardiopulmonary bypass, through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation TCA, TTPA, Anti-Xa, heparin bioavailable and loss of excessive blood (bleeding) at the end of the surgery.

NCT ID: NCT00894959 Completed - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin in Patients

Start date: July 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is verify, through a randomized, single-blind, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery at that require the aid of cardiopulmonary bypass, through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation TCA, TTPA, Anti-Xa, heparin bioavailable and loss of excessive blood (bleeding) at the end of the surgery.

NCT ID: NCT00894829 Completed - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin (Eurofarma)

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify, through a randomized, single-blind, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery at that require the aid of cardiopulmonary bypass, through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation TCA, TTPA, Anti-Xa, heparin bioavailable and loss of excessive blood (bleeding) at the end of the surgery.

NCT ID: NCT00894673 Completed - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients

HEPSBCCV0109
Start date: July 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify, through a randomized, single-blind, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery at that require the aid of cardiopulmonary bypass, through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation TCA, TTPA, Anti-Xa, heparin bioavailable and loss of excessive blood (bleeding) at the end of the surgery.

NCT ID: NCT00894621 Active, not recruiting - Clinical trials for Mechanical Ventilation

Norepinephrine as Early Vasopressor Therapy in Children Undergoing Mechanical Ventilation

Start date: November 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effectiveness from early infusion of norepinephrine in pediatric patients submitted to mechanical ventilation for the use of sedative and analgesics drugs.

NCT ID: NCT00894387 Completed - Clinical trials for Congestive Heart Failure

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

ASTRONAUT
Start date: May 2009
Phase: Phase 3
Study type: Interventional

This study evaluated the effect of early initiation of aliskiren therapy, compared to standard therapy, in the reduction of cardiovascular death and heart failure re-hospitalization events within 6 months, in congestive heart failure (CHF) patients hospitalized for an episode of acute decompensated heart failure.

NCT ID: NCT00893867 Terminated - Clinical trials for Acute Ischemic Stroke

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

MACSI
Start date: December 2009
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine if intravenous administration of the metal ion trapping agent DP-b99 up to 9 hours following acute ischemic stroke onset, and then for 3 additional days (4 consecutive days in total) is effective in improving long term outcome. Patients will be followed up for 3 months after the stroke.

NCT ID: NCT00893802 Completed - Periodontal Disease Clinical Trials

Influence of Periodontal Treatment During Pregnancy in Adverse Pregnant Outcomes

Start date: August 2001
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effects of treatment of periodontal disease during the second trimester of gestation in adverse pregnancy outcomes. Pregnant patients during the 1st and 2nd trimesters at antenatal care in a Public Health Center will be divided into two groups: NIG- 'no intervention' or IG- 'intervention,' according to agreement in receive periodontal treatment during pregnancy. Treatment will be performed by a single periodontist consisting of scaling and root planning (SRP), professional prophylaxis (PROPH) and oral hygiene instruction (OHI). Patients at NIG will receive PROPH and OHI during pregnancy and will be referred for treatment after delivery. Periodontal evaluation will be performed by a single trained examiner, blinded to periodontal treatment, according to probing depth (PD), clinical attachment level (CAL), plaque index (PI) and sulcular bleeding index (SBI) at baseline and 35 gestational weeks-28 days post-partum. Primary adverse pregnancy outcomes to be addressed are: preterm birth (< 37 weeks), low birth weight (< 2.500 Kg), late abortion (14-24 weeks) or abortion (< 14 weeks). The results obtained will be statistically evaluated according to OR, unpaired t test and paired t test. It is expected that periodontal treatment during the second trimester of gestation will result in decreased rates of adverse pregnancy outcomes.